Educational guide
Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL) 1 mg
Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL) US$178.10 Excluding tax and shipping fees In stock Description About Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL) The BK Polyomavirus (BKV) Major capsid protein VP1 Peptide is a high quality epitope peptide for
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL)
US$178.10
Excluding tax and shipping fees
In stock
Description
About Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL)
The BK Polyomavirus (BKV) Major capsid protein VP1 Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Major capsid protein VP1 Peptide, H-AITEVECFL-OH (Uniprot: P14996 aa: 44-52) from JPT is produced under strict quality control and quality management.
Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL) - Specifications
Peptide sequence: H-AITEVECFL-OH
Amount: 1 mg
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Delivery Format: Freeze-dried in plastic vial
Application(s): T-cell immunity
Condition(s)/Topic(s): Merkel cell carcinoma, Nephritis, interstitial
Standard Delivery Time: approx. 10 days
Your Custom or Scrambled Antigen Peptide!
Do you need a scrambled version of this antigen peptide?We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!
Are you interested in other antigen peptides?Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis
JPT’s Antigen PeptidesFind your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Benefits of JPT’s Antigen Peptides- All peptides are made in Germany- Bulk orders or custom peptide snythesis upon request- Synthesis protocols designed to avoid toxic contaminants and side products - Provision of freeze dried aliquots for enhanced stability - Proven track record for applications in clinical studies- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL)
References:Read References with Antigen Peptides
Documentation
Documentation for Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL)
Protocol_PepMix.pdf
BKV-VP1-AITEVECFL-2.pdf
Properties
Properties of Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL)
T-cell immunity
Antigen Peptides
Merkel cell carcinoma, Nephritis, interstitial
Freeze-dried in plastic vial
BK Polyomavirus (BKV)
Major capsid protein VP1
Trial Grade: each peptide purified to > 90% (HPLC/MS)
No
Further Information to Antigen Peptide BKV VP1 HLA-A*0201 (AITEVECFL)
Values
H-AITEVECFL-OH
9mer peptide as TFA salt